These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4625718)

  • 1. Preliminary studies on the efficacy of Bayer 2502 (lampit) for treatment of Trypanosoma cruzi (strain 7) infection in CF1 mice.
    Marsden PD; Miles MA; Patterson JW; Pettitt LE
    Trans R Soc Trop Med Hyg; 1972; 66(3):508-9. PubMed ID: 4625718
    [No Abstract]   [Full Text] [Related]  

  • 2. [(Effect of Lampit on experimental Trypanosoma cruzi infection in mice)].
    Apt W; Mancilla R; Díaz M; Díaz S
    Bol Chil Parasitol; 1972; 27(3):80-6. PubMed ID: 4196829
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of length of treatment with Bayer 2502 on isolation of Trypanosoma cruzi and resistance to challenge in the mouse.
    Morrow DT; Wescott RB; Davis WC
    Am J Trop Med Hyg; 1977 May; 26(3):382-6. PubMed ID: 405877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A bioactive biflavonoid from Campnosperma panamense.
    Weniger B; Vonthron-Sénécheau C; Arango GJ; Kaiser M; Brun R; Anton R
    Fitoterapia; 2004 Dec; 75(7-8):764-7. PubMed ID: 15567260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-(substituted)benzyl-5-aminoimidazole-4-carboxamides are potent orally active inhibitors of Trypanosoma cruzi in mice.
    Chabala JC; Waits VB; Ikeler T; Patchett AA; Payne L; Peterson LH; Reamer RA; Hoogsteen K; Wyvratt M; Hanson WL
    Experientia; 1991 Jan; 47(1):51-3. PubMed ID: 1900244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The therapeutic effect of allopurinol on American trypanosomiasis (Chagas disease) in CFW mice].
    Castrillón Rivera LE; García Fernández W; Pérez Gutiérrez C
    Salud Publica Mex; 1984; 26(2):146-54. PubMed ID: 6427943
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiprotozoal drug nitazoxanide enhances parasitemia, tissue lesions and mortality caused by Trypanosoma cruzi in murine model.
    Valle-Reyes JS; Melnikov V; Dobrovinskaya O; Rodriguez-Hernández A; Wookee-Zea C; Pimientel-Rodrigez V; Rueda-Valdovinos G; Delgado-Enciso I; López-Lemus UA; Espinoza-Gómez F
    Exp Parasitol; 2017 Jan; 172():44-50. PubMed ID: 28011170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trypanosoma cruzi: a novel chemical class (nitrobenzofurans) active against infections of mice (Mus musculus).
    Kinnamon KE; Poon BT; Hanson WL; Waits VB
    Exp Parasitol; 1998 Jun; 89(2):251-6. PubMed ID: 9635449
    [No Abstract]   [Full Text] [Related]  

  • 9. Thioridazine treatment modifies the evolution of Trypanosoma cruzi infection in mice.
    Rivarola HW; Fernández AR; Enders JE; Fretes R; Gea S; Suligoy M; Palma JA; Paglini-Oliva P
    Ann Trop Med Parasitol; 1999 Oct; 93(7):695-702. PubMed ID: 10715697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, structure-activity relationship and in vivo efficacy of piperazine analogues of fenarimol as inhibitors of Trypanosoma cruzi.
    Keenan M; Alexander PW; Diao H; Best WM; Khong A; Kerfoot M; Thompson RC; White KL; Shackleford DM; Ryan E; Gregg AD; Charman SA; von Geldern TW; Scandale I; Chatelain E
    Bioorg Med Chem; 2013 Apr; 21(7):1756-63. PubMed ID: 23462713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trypanocidal activity of the phenyl-substituted analogue of furamidine DB569 against Trypanosoma cruzi infection in vivo.
    de Souza EM; Oliveira GM; Boykin DW; Kumar A; Hu Q; De Nazaré C Soeiro M
    J Antimicrob Chemother; 2006 Sep; 58(3):610-4. PubMed ID: 16854954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on benznidazole for the treatment of patients with Chagas disease.
    Thakare R; Dasgupta A; Chopra S
    Drugs Today (Barc); 2018 Jan; 54(1):15-23. PubMed ID: 29569658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risedronate in the treatment of Murine Chagas' disease.
    Bouzahzah B; Jelicks LA; Morris SA; Weiss LM; Tanowitz HB
    Parasitol Res; 2005 Jun; 96(3):184-7. PubMed ID: 15844009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nifurtimox, a bright future for treatment of Chagas disease].
    Wolf A; Boulliat C; Coillot C; Rouault M; Gaillard K; Beranger C; Oliver M
    Med Trop (Mars); 2011 Apr; 71(2):131-3. PubMed ID: 21695868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The urgent need to develop new drugs and tools for the treatment of Chagas disease.
    Muñoz MJ; Murcia L; Segovia M
    Expert Rev Anti Infect Ther; 2011 Jan; 9(1):5-7. PubMed ID: 21171870
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of novel benznidazole solutions during the experimental infection with Trypanosoma cruzi.
    Manarin R; Lamas MC; Bottasso E; Serra E; Revelli S; Salomón CJ
    Parasitol Int; 2013 Feb; 62(1):79-81. PubMed ID: 22975280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of triaminoquinazolines against Trypanosoma cruzi in mice.
    Thompson PE; Bayles A
    J Parasitol; 1970 Jun; 56(3):616-7. PubMed ID: 4986980
    [No Abstract]   [Full Text] [Related]  

  • 18. Follow-up of an asymptomatic Chagas disease population of children after treatment with nifurtimox (Lampit) in a sylvatic endemic transmission area of Colombia.
    Bianchi F; Cucunubá Z; Guhl F; González NL; Freilij H; Nicholls RS; Ramírez JD; Montilla M; Flórez AC; Rosas F; Saavedra V; Silva N
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003465. PubMed ID: 25723465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trypanocidal nitroarene treatment of experimental Trypanosoma cruzi infection does not prevent progression of chronic-phase heart lesions in rabbits.
    Teixeira AR; Cunha Neto E; Rizzo LV; Silva R
    J Infect Dis; 1990 Dec; 162(6):1420. PubMed ID: 2121842
    [No Abstract]   [Full Text] [Related]  

  • 20. Trypanocidal drugs: mechanisms, resistance and new targets.
    Wilkinson SR; Kelly JM
    Expert Rev Mol Med; 2009 Oct; 11():e31. PubMed ID: 19863838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.